Long-term responders to PD-1 blockade in patients with advanced non-small cell lung cancer (NSCLC).

被引：0
|
作者：
Luo, Jia
Bandlamudi, Chaitanya
Ricciuti, Biagio
Vokes, Natalie
Schoenfeld, Adam Jacob
Egger, Jacklynn, V
Sauter, Jennifer L.
Plodkowski, Andrew J.
Preeshagul, Isabel Ruth
Kris, Mark G.
Van Allen, Eliezer Mendel
Taylor, Barry S.
Rizvi, Hira
Donoghue, Mark
Awad, Mark M.
Hellmann, Matthew David
机构：
[1] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[2] Dana Farber Canc Inst, Lowe Ctr Thorac Oncol, Boston, MA 02115 USA
[3] Dana Farber Canc Inst, Boston, MA 02115 USA
[4] Massachusetts Gen Hosp, Cambridge, MA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
9549
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Impact of age on outcomes with PD-(L)1 blockade in patients (Pts) with non-small cell lung cancer (NSCLC).
    Lichtenstein, Morgan
    Nipp, Ryan David
    Goodwin, Kelly
    Anderson, Danyon
    Newcomb, Richard
    Gainor, Justin F.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [42] Combination therapy with PD-1/PD-L1 blockade in non-small cell lung cancer: strategies and mechanisms
    Huang, Mu-Yang
    Jiang, Xiao-Ming
    Wang, Bing-Lin
    Sun, Yang
    Lu, Jin-Jian
    PHARMACOLOGY & THERAPEUTICS, 2021, 219
  • [43] The incidence of gastrointestinal adverse events in patients with advanced non-small cell lung cancer (NSCLC) treated with PD-1 inhibitors: a meta-analysis
    Huo, Geng-Wei
    Zhu, Fu-Yi
    Zuo, Ran
    Song, Ying
    Chen, Wei-Dong
    Chen, Wen-Ming
    Zhang, Hong-Mei
    Jia, Sha-Sha
    Chen, Peng
    TRANSLATIONAL CANCER RESEARCH, 2021, 10 (07) : 3389 - 3403
  • [44] Long-term survivors after chemotherapy in advanced non-small cell lung cancer
    Satoh, Hiroaki
    Ishikawa, Hiroichi
    Ohara, Gen
    Kagohashi, Katsunori
    Kurishima, Koichi
    Ohtsuka, Morio
    Hizawa, Nobuyuki
    ANTICANCER RESEARCH, 2007, 27 (6C) : 4457 - 4460
  • [45] A COMPREHENSIVE CLINICAL AND GENOMIC CHARACTERIZATION OF LONG-TERM RESPONDERS RECEIVING IMMUNE CHECKPOINT BLOCKADE FOR METASTATIC NON-SMALL CELL LUNG CANCER
    Ghanem, Paola
    Murray, Joseph
    Hsu, Melinda
    Ettinger, David
    Feliciano, Josephine
    Forde, Patrick
    Hann, Christine
    Lam, Vincent
    Levy, Benjamin
    Brahmer, Julie
    Marrone, Kristen
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A320 - A320
  • [46] PD-1 antibody pembrolizumab administered at non-standard frequency in non-small cell lung cancer (NSCLC).
    Sehgal, Kartik
    Shea, Meghan
    McDonald, Danielle M.
    Huberman, Mark
    Weiss, Glen J.
    VanderLaan, Paul A.
    Costa, Daniel Botelho
    Rangachari, Deepa
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [47] Predictive factors for long-term responders of pemetrexed maintenance treatment in non-small cell lung cancer
    Yoon, Joon-Young
    Park, Cheol-Kyu
    Choi, Yoo-Duk
    Oh, In-Jae
    Kim, Young-Chul
    THORACIC CANCER, 2019, 10 (04) : 942 - 949
  • [48] Evaluation of PD-L1/PD-1 on circulating tumor cells (CTCs) and on primary tumor in advanced non-small cell lung cancer (NSCLC)
    Kallergi, Galaktea
    Vetsika, Eleni Kyriaki
    Aggouraki, Despoina
    Lagoudaki, Eleni
    Koutsopoulos, Anastasios
    Koinis, Filippos
    Katsarlinos, Panagiotis
    Trypaki, Maria
    Stournaras, Christos
    Georgoulias, Vassilis
    Kotsakis, Athanasios
    CANCER RESEARCH, 2017, 77
  • [49] Differential immune-related microenvironment determines PD-1/PD-L1 blockade efficacy in advanced non-small cell lung cancer patients.
    Shirasawa, Masayuki
    Yoshida, Tatsuya
    Shimoda, Yukiko
    Takayanagi, Daisuke
    Shiraishi, Kouya
    Kubo, Takashi
    Mitani, Sachiyo
    Matsumoto, Yuji
    Masuda, Ken
    Shinno, Yuki
    Okuma, Yusuke
    Goto, Yasushi
    Horinouchi, Hidehito
    Ichikawa, Hitoshi
    Kohno, Takashi
    Yamamoto, Noboru
    Watanabe, Shun-ichi
    Motoi, Noriko
    Ohe, Yuichiro
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [50] Interleukin 8 in plasma is an efficacy marker for advanced non-small cell lung cancer treated with hypofractionated radiotherapy and PD-1 blockade
    Kang, Pengyuan
    Liu, Dan
    Li, Lin
    Guo, Xiyuan
    Ye, Yingchun
    Li, Yunfei
    Jiang, Qin
    Lin, Sheng
    Yuan, Qing
    CYTOKINE, 2023, 163
12345